{"brief_title": "Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients", "brief_summary": "The incidence of efficacy failure at 12 months between two regimens.", "condition": ["Chronic Kidney Failure", "Graft vs Host Disease", "Kidney Transplantation"], "intervention_type": ["Drug"], "intervention_name": ["Rapamune"], "criteria": "Inclusion Criteria - Age: 13 years or older, 40 kgs or more - End-stage renal disease - African-American/Black transplant recipient and/or repeat renal transplant recipient who lost a previous allograft Exclusion Criteria - Evidence of active infection - Evidence abnormal chest x-ray - Patients with HIV.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Kidney Transplant", "mesh_term": ["Renal Insufficiency", "Graft vs Host Disease", "Kidney Failure, Chronic", "Sirolimus", "Everolimus"], "id": "NCT00044720"}